Efficacy and safety of low ‐dose urokinase for the treatment of hemodynamically stable AECOPD patients with acute pulmonary thromboembolism

Conclusions: The incidence of PTE in AECOPD patients was 22.9%, especially with higher occurrence rate in severe COPD. Compared with anticoagulation‐only therapy, low‐dose UK treatment (500000IU/d for 5‐7 days) could obtain a better efficacy and safety in hemodynamically stable AECOPD patients with acute PTE, corresponding with a higher effective rate (97.2%) and lower adverse events rate (8.3%) respectively. This article is protected by copyright. All rights reserved.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Original Article Source Type: research